Bond.az White LogoBond.az Black Logo

Benchmark Reiterates Hold on Dine Brands Stock

Benchmark reiterates Hold on Dine Brands Global shares after $100 million buyback plan. Stock up 9.3% last week.

Matthew King
ByMatthew King- Senior Editor
|
0

Benchmark reaffirmed a Hold rating on Dine Brands Global (NYSE:DIN) after the company announced a $100 million share repurchase program.

The new authorization adds to an existing program from February 2022, which had about $51 million remaining. Combined, Dine Brands has roughly $151 million for buybacks.

Full utilization could repurchase about 35% of shares outstanding. The stock gained 9.3% over the past week, though analysts suggest it trades above fair value.

Dine Brands also reported strong Q1 2026 results: EPS of $1.07 (beat by 5.94%) and revenue of $225.2 million (1.15% above estimates).

More News
Today / 13:50
|
208

Piper Sandler Raises Biogen Target to $225

Piper Sandler raises Biogen price target to $225 from $214. Phase II trial of BIIB080 missed primary endpoint but showed slowing of clinical decline at lowest dose.

0
Today / 13:44
|
314

Piper Sandler reiterates Boston Properties stock rating

Piper Sandler reaffirms Overweight rating on Boston Properties stock with $75 target. AI demand driving office market changes.

0
Today / 13:03
|
202

Benchmark maintains Texas Roadhouse Hold rating

Benchmark maintains Texas Roadhouse Hold rating. Stock at $177.06, analyst targets $165-$234.

0
Today / 13:02
|
431

GEN Restaurant Group Hold maintained

Benchmark maintains Hold on GEN Restaurant Group after Q1 2026 results miss estimates on revenue and profit.

0
Today / 12:25
|
786

Orrstown Gets Neutral Rating from DA Davidson

DA Davidson gives Orrstown Financial a neutral rating with $41 target. Strong deposit base and 11-year dividend growth highlight the bank's stability.

0
Today / 12:23
|
658

DA Davidson Initiates Unity Bancorp with Buy Rating

DA Davidson initiates Unity Bancorp with buy rating and $68 target. Strong growth outlook and dividend history highlighted.

0
Today / 12:04
|
583

Bitdeer Price Target Raised to $19 by Needham

Needham raised Bitdeer price target to $19, maintaining Buy. Tydal discussions advanced; stock up 40% in 6 months.

0
Today / 12:03
|
373

Solventum stock Outperform rating by Wedbush

Wedbush initiates Solventum coverage at Outperform with $94 target. Activist Trian pushes for portfolio simplification. Stock trades at $74.42.

0
Today / 12:02
|
275

Needham Cuts Cellebrite Target to $15 on Valuation

Needham lowered Cellebrite price target to $15 from $18, maintaining Buy. Strong Q1 results, growth products doubling, and FedRAMP authorization highlight the company's performance.

0
Today / 11:43
|
444

Prestige Brands Price Target Cut to $72 by Canaccord

Canaccord cuts Prestige Brands price target to $72 after sales miss. Despite challenges, the company eyes growth through acquisitions.

0
Today / 11:32
|
467

Canaccord Reaffirms GH Research Stock Rating on Phase 3 Progress

Canaccord Genuity keeps Buy rating on GH Research stock as Phase 3 program for GH001 advances. Key financial highlights included.

0
Today / 11:30
|
644

Biogen Stock: Alzheimer Drug Shows Promise

Biogen's Alzheimer drug diranersen shows positive Phase 2 results. Stock analysis and future outlook from Bond.az.

0
...
Benchmark Reiterates Hold on Dine Brands Stock | Bond.az